So sánh phương pháp

	Phân tích Tương quan Liều-Đáp ứng Bayes	Phân tích sống còn
Lĩnh vực	Dịch tễ học	Thống kê nghiên cứu
Họ	Process / pipeline	Process / pipeline
Năm ra đời	1990s–2000s (Bayesian formalization)	1958
Người khởi xướng	Developed from classical frequentist dose-response traditions; Bayesian formulations advanced by Dempster, Gelman, and colleagues	Edward L. Kaplan and Paul Meier
Loại	Statistical modeling approach	Method
Công trình gốc	Gelman, A., Carlin, J. B., Stern, H. S., Dunson, D. B., Vehtari, A., & Rubin, D. B. (2013). Bayesian Data Analysis (3rd ed.). CRC Press. ISBN: 978-1439840955	Kaplan, E. L., & Meier, P. (1958). Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53(282), 457–481.
Tên gọi khác	Bayesian DRA, Bayesian dose-response modeling, Bayesian benchmark dose analysis, BDR	Kaplan-Meier analysis, Cox regression, TTE analysis
Liên quan	3	3
Tóm tắt	Bayesian dose-response analysis models the relationship between the level of exposure (dose) to a substance and the magnitude or probability of a biological response, embedding that model in a Bayesian probabilistic framework. Unlike frequentist approaches that yield a single point estimate with confidence intervals, the Bayesian framework produces a full posterior distribution over model parameters, allowing explicit quantification of uncertainty, incorporation of prior scientific knowledge, and principled model averaging. It is widely applied in toxicology, pharmacology, environmental risk assessment, and clinical dose-finding studies.	Survival analysis is a collection of statistical methods for modeling time from a defined starting point until an event of interest occurs (disease, recovery, death, equipment failure). Kaplan and Meier's nonparametric estimator (1958) and David Cox's proportional hazards model (1972) jointly enabled analysis of censored data—individuals whose event times are unknown because they left the study or were still event-free at follow-up. Indispensable in oncology, cardiology, infectious disease research, engineering reliability, and any field where time-to-event matters.